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Catalytic carbene transfer allows the direct
customization of cyclic purine dinucleotides†
Na Fei,a Daniel Ha¨ussinger,a Seraina Blu¨mli,a Benoıˆt-Joseph Laventie,b
Lorenzo D. Bizzini,a Kaspar Zimmermann,a Urs Jenalb and Dennis Gillingham*a
We describe a simple method for the direct modification of nucleo-
bases in cyclic purine dinucleotides, important signalling molecules
in both prokaryotes and eukaryotes. The method tolerates all
members of the cyclic dinucleotide family and could be used to
modulate their function or introduce useful side-chains such as
fluorophores and photo-crosslinking groups.
30,50- and 20-50-linked cyclic dinucleotides (CDNs, see Fig. 1) play
diverse and important roles in biology. The cyclic diguanylate
derivative (c-di-GMP) is a ubiquitous secondary messenger in
prokaryotes.1 Fluctuating levels2 of c-di-GMP regulate a range of
bacterial cell functions including motility, adhesion, cell-to-cell
communication, exopolysaccharide synthesis, biofilm formation
and virulence.3 More recently, c-di-AMP was identified as an
important signalling molecule in gram-positive bacteria.4 More-
over recent evidence suggests that humans endogenously pro-
duce the unusual CDN c-G(20,50)pA(30,50)p as part of their innate
immune response to cytoplasmic dsDNA and dsRNA.5 Given the
diverse roles of CDNs in prokaryotes and eukaryotes, it would be
helpful to have probe molecules that could perturb the function
of each CDN specifically and independently. Furthermore struc-
tural analogues able to evade an immune response or specifically
interfere with the mammalian immune system might open the
door to CDN derived therapeutics.6
Unravelling and reprogramming the complex biology of CDNs
hinges on the ready availability of chemically tailored variants.
While total chemical synthesis gives access to any variation,
substantial expertise and labour are required.7 Semi-syntheses
from the natural CDNs are simpler, but until now these have
focussed on changes in the phosphate linkage or 20 position of the
ribose (see Fig. 2).8 We report here that catalytic rhodium-based
carbene transfer oﬀers a one-step method to target the exocyclic
amine of nucleobases in all types of natural 30-50-linked CDNs.
Direct nucleobase modification has never been explored, but
would provide an important complement to previous approaches.
Rhodium catalysed carbene reactions represent an emerging
technology in chemical biology.9 We have recently developed
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Fig. 1 Structures of the natural CDNs and a phosphorothioate derivative (c-di-GMPS) engineered for phosphodiesterase resistance.
Fig. 2 CDN sites that can be targeted through direct modification of
the natural compounds or with commercial phosphoramidites of the
canonical bases.
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Rh-catalysed N–H insertion with diazo compounds as a method
for modifying nucleobases in DNA and RNA.10 While the
technique is unselective in long single-stranded oligos, CDNs
presented the more tractable problem of selecting between only
two reactive N–H groups. A handful of diazo compounds
bearing common functional tags (amine for water solubility,
azide for photo-crosslinking, alkyne for click chemistry) were
synthesized and tested with CDNs (see Table 1). The reactions
delivered mainly mono-modified CDNs along with some unpro-
ductive O–H insertion of the diazo starting material with water
(hence 10 equivalents are required); in some cases minor double-
modified products were also observed (0–18%). As shown in Table 1
the conversions ranged from 33–80% depending upon the precise
substrate and diazo compound. The reactions are fast, requiring at
most 2 h to reach completion (entries 1–3). For example, aryl azide
modified c-di-GMP (entry 4, Table 1) delivered 58% conversion in
just 20 minutes. We also investigated the phosphodiesterase resis-
tant phosphorothioate derivative c-di-GMPS. Sulphur derivatives
often hinder carbene transfer reactions, but in this case phosphoro-
thioates were well-tolerated, delivering 80% conversion and 41%
isolated yield (entry 6).
One unexpected observation in Table 1 relates to the mixed
dinucleotide c-GAMP: in the case of the dimethylamino derived
diazo compound a mixture of guanine and adenine modified
products were obtained in a 2 : 1 mixture according to HPLC
analysis (entry 3), but with the azide containing diazo substrate
targeting of the guanine was far more selective (entry 5,480%
selectivity for G alkylation according to integration of HPLC).
The structures of the products were gleaned independently from
NMR (ROESY, HMQC, and HMBC, see the ESI† for details) and
MS–MS fragmentation (Fig. 3). With the sample from entry 3 in
Table 1, the major mass peaks matched the guanine-modified
structure (see panel A, Fig. 3). In contrast, the minor product
from entry 3 in Table 1 delivered the modified adenine fragment
(panel b, Fig. 3); while the azide-containing diazo substrate
(entry 5) almost exclusively targeted the guanine (panel c, Fig. 3).
Alkylation on the phosphate was ruled on the basis that there was a
strong HMBC correlation between the a-hydrogen derived from the
diazo substrate and the nearest carbon on the nucleobase in each
case. We had expected that the unsymmetrical CDN c-GAMP would
represent a substantial challenge in chemoselectivity since adenine
and guanine display similar functional groups to the catalyst.
However, as entries 3 and 5 demonstrate, the substrate can play
a role in controlling the site-selectivity. The source of the change
could be related to the charge of the dimethylamino group, or the
propensity of certain CDNs to form higher-order aggregates in
solution.11 Although the productmixture obtained from entry 3 was
more complex, we were able to separate each component (the 39%
reported yield corresponds to the mixture) and therefore c-GAMP
derivatives are available with alterations at either base through one
protocol.
In prokaryotes CDNs are involved in a complicated regulatory
network involving amultitude of individual protein components12
and several riboswitches.13 The modified CDN derivatives shown
in Table 1 are versatile starting points for exploring the biology of
these second messenger molecules. For example, the azide motif
can be converted to a fluorescent CDN derivative through a
catalytic azide–alkyne cycloaddition (see the ESI,† Fig. S30–S34
for an example). Furthermore, the aryl azide itself is a common
photo-crosslinking group and therefore compounds such as those
Table 1 Rh-catalysed N–H insertion of CDNs with diazo compounds
Entry CDN Ar Main product
Time
(min)
Conv (%)
(yield)a
1 c-di-GMP 120 51 (39)
2 c-di-AMP 120 33b
3 c-GAMP 120 73 (39)
4 c-di-GMP 20 58 (31)
5 c-GAMP 60 67 (22)
6 c-di-GMPS 50 80 (41)
7 c-di-GMP 120 30b
a Yield after prep-HPLC. b Yield not determined due to low conversion.
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found in Table 1 (entries 4–6) could be used to probe binding sites
of c-di-GMP receptors. Although 20-hydroxyl derived probes are
known,8b,14 a family of photo-crosslinkers is important since
different receptors will have different binding constraints.
To explore the photo-crosslinking of azide-modified CDNs we
selected the known c-di-GMP receptor DgrA – a PilZ homolog that
mediates c-di-GMP-dependent control of Caulobacter crescentus cell
motility.15 Its high affinity and specificity towards c-di-GMP and the
availability of binding mutants make this protein an ideal test bed.
The aryl azide modified c-di-GMP (c-di-GMP-N3) was incubated
with the protein for 15 h under 366 nm irradiation (see top of
Fig. 4) and the mixtures were analysed by high-resolution ESI mass
spectrometry, gel electrophoresis, MALDI-TOF, and finally the
site of modification was determined by a trypsin digest (see the
ESI,† Fig. S35–S39 for details). Even with a single equivalent of
c-di-GMP-N3 (lane 3) DgrA was covalently modified in a yield of
17% (according to integration of the gel bands). At 10 equivalents of
c-di-GMP-N3 there was complete conversion (lane 8), but the diffuse
bands suggested competitive unspecific modification. Previous work
has shown that Arg11, Arg12, and Trp75 are important residues for
c-di-GMP binding of dgrA: a W75A mutant decreased binding
102–103-fold, while binding was completely abrogated in the
R11A/R12A double mutant.15 Consistent with the reported
binding studies, reaction of c-di-GMP-N3 with the W75A mutant
gave reduced crosslinking (cf. lane 5 versus lane 3) and the
R11A/R12A was not detectably modified (lane 7). A trypsin
digest of the photo-crosslinking reaction revealed one new peak
in the LC-MS whose mass was consistent with modification of the
GGR peptide fragment shown in red in Fig. 3. This tripeptide sits
directly in the region of the purported c-di-GMP binding site (blue in
Fig. 3). Taken together these results demonstrate that c-di-GMP-N3
is a selective cross-linking probe efficient enough to determine
binding sites in CDN receptors.
While the cross-linking data provided qualitative validation that
N2-modified c-GMP derivatives maintained their ability to bind
DgrA, microscale thermophoresis gave a quantitative measure of
binding. In panel A of Fig. 5 is a comparison of binding to DgrA of
c-di-GMP-N3 and c-di-GMP. The modified CDN still bound with a
Fig. 3 MS–MS analysis of alkylation products. Panel A: the major product
from entry 3 in Table 1 delivered a daughter ion consistent with guanine
alkylation; panel B: the minor product was consistent with adenine
alkylation; panel C: the only isolated product from entry 5 in Table 1
delivered a daughter ion consistent with guanine alkylation.
Fig. 4 Modified c-di-GMP-N3 maintains binding to DgrA and can be used for
photo-crosslinking. The peak at 14059.2 is likely a post-translational modifica-
tion which is also cross-linked with the azide compound (14910.7). The baseline
impurities in the ESI stem from gradual photolytic degradation of DgrA.
Fig. 5 Microscale thermophoresis confirms that c-di-GMP-N3 maintains
strong binding to DgrA (panel A). The W75A mutant loses aﬃnity for c-di-GMP
and c-di-GMP-N3 to the same extent (panel B).
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nanomolar aﬃnity – less than a 3-fold change over the native
interaction. Consistent with the cross-linking experiments the
W75A DgrA mutant showed substantially attenuated binding (see
panel b, Fig. 5), but again the modified CDN bound at a similar
level as the natural CDN, further validation that the exocyclic amine
is a viable site for modification in the study of CDN biology.
In summary, we describe a direct method for the synthesis of
CDN derivatives modified at the exocyclic amine of the purine
bases. The reaction is trivial to execute, making it accessible to
non-experts in synthesis and catalysis. The most synthetically
challenging aspect of the approach is in the synthesis of the
diazo compounds, which typically require 3–5 operations.
New aspects of CDN biology are continually being unveiled.
A challenge for chemical biologists is to provide a selective
probe for each natural CDN receptor. The process we have
described adds a new method for such bespoke probe develop-
ment. We are currently cataloguing how modifications of the
exocyclic amine of CDNs behave with other receptors. A detailed
understanding of the diﬀerent binding requirements of prokaryotic
versus eukaryotic receptors will pave the way to creating CDN
inspired therapeutics.
Mr Ananth Rao is gratefully acknowledged for assistance
with some of the NMR assignments and interpretation.
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